Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
CPSC recall 23146. Recall date: .
Hazard, in the words of CPSC
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Remedy, in the words of CPSC
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
CPSC recall 23146 has the recall date 9 Mar 2023. The notice names the firm Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream). The recall has about 156,750 units. The median CPSC recall of 2023 has 7,250 units. This register puts the recall under the hazard Poisoning.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
CPSC publishes these words. Source: CPSC recall notices, section About the U.S. CPSC, read on . The hazard, the remedy and the incident text on this site are the words of the CPSC recall notice. Newest CPSC recall on the register: .
More of the notice
The hazard and the remedy are at the top of the page. Each quotation is the text of CPSC.
| Incidents and injuries | None reported |
|---|---|
| Units | 156,750 |
| Remedy options | New Instructions, Repair |
| Description | This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name "Sandoz," the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings "This unit-dose packaging is not child-resistant" and "For institutional use only" are listed on the carton. The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name "fougera®," the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning "FOR HOSPITAL USE ONLY" is printed on the carton and the tube. Product Description NDC Number Lot Number Expiration Date Aprepitant Capsules 125 mg 0781-2323-68 Carton of 1 Blister Pack of 6 capsules 0781-2323-06 Blister Pack LK3209 LC6454 04/2024 12/2023… |
| Product | Aprepitant capsules and Lidocaine and Prilocaine cream, About 156,750 |
| Sold at | Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors. |
| Manufacturer | Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream) |
| Importer | Sandoz Inc., of Princeton, New Jersey (Aprepitant Capsules) |
| Made in | Slovenia (Aprepitant Capsules), United States (Lidocaine and Prilocaine cream) |
Recall notice: The page that CPSC publishes for one recall of a consumer product. It states the product, the hazard, the remedy and the incidents.
Hazard: The way a product can cause harm, in the words of the CPSC recall notice. This site also puts each recall under short hazard names.
Remedy: What the manufacturer or the firm does about a recalled product. The agency record states the remedy of each recall.
Units: The number of vehicles or products that a recall can include. The manufacturer or the firm reports the number to the agency.
The recall in context
- Units in this recall
- 156,750Median of 2023: 7,250
- CPSC recalls of 2023
- 324
- Recalls of 2023 with one of the same hazards
- 11%
- Recalls on the register that name Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
- 1
Official channels
- CPSC recall notice 23146The notice on the CPSC site, with the pictures and the contact of the firm.
- CPSC recallsThe list of all recall notices on the CPSC site.
- SaferProducts.govThe CPSC site for a report about a consumer product.
Follow by RSS:Consumer product recalls
Cite this page
Recall Register. CPSC recall 23146. https://recallregister.com/product/9556-sandoz-recalls-aprepitant-capsules-and-lidocaine-and-prilocaine-cream/. Source: CPSC Recall Retrieval Web Services. Data through .
Sources
- Source
- US Consumer Product Safety Commission
- Licence
- US government work, public domain
- Data retrieved
- 30 Sep 2026
- Newest CPSC recall on the register
- 24 Sep 2026
The CPSC notice is the authority. The hazard names come from the hazard text of CPSC. The category is the product type that CPSC gives. How the register is made. Report an error.
Questions
- Does CPSC recall 23146 report injuries?
- The CPSC notice says:
None reported
- Where was the product sold?
- The CPSC notice says:
Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
- Which remedy options does CPSC list for recall 23146?
- CPSC lists 2 remedy options:
New Instructions, Repair
- How many units are in CPSC recall 23146?
- The CPSC notice gives this number:
About 156,750